Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

EMA – Strengthening supply chain of anti-D immunoglobulins

EMA and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), have issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins.

These medicines are currently the only available treatment for the prevention of RhD immunisation during pregnancy. RhD immunisation happens when a pregnant person with RhD-negative blood type is exposed to RhD-positive blood from their foetus. This can lead to an immune reaction that can seriously impact the health of the foetus, and later of the newborn, and have potentially fatal outcomes.

More information on the EMA Website.


OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (20 septembre 2025). EMA – Strengthening supply chain of anti-D immunoglobulins. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/14pwd


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.